financetom
Business
financetom
/
Business
/
Update: Market Chatter: Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off
May 6, 2024 9:45 AM

12:17 PM EDT, 05/06/2024 (MT Newswires) -- (Updates with additional information)

Bank of America ( BAC ) and BNP Paribas are expected to become lead advisers in Sanofi's ( SNY ) separation of its consumer-health business, Bloomberg reported Monday, citing people familiar with the matter.

Sanofi ( SNY ) is planning to hire two banks and may consider adding up to two additional banks to work on the transaction, Bloomberg reported. The advisers group has not been finalized and could change. The drugmaker does not expect any transaction to occur before Q4, the report said.

Sanofi ( SNY ) is looking a number of options, including sale, but is siding with a capital markets transaction to create a listed entity in France. In case of a deal, the unit is considered to be valued at around $20 billion, Bloomberg reported in February.

Bank of America ( BAC ), Sanofi ( SNY ), and BNP did not immediately respond to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 37.54, Change: +0.29, Percent Change: +0.78

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TE Connectivity Fiscal Q3 Adjusted Earnings Rise, Net Sales Lower
TE Connectivity Fiscal Q3 Adjusted Earnings Rise, Net Sales Lower
Jul 24, 2024
06:57 AM EDT, 07/24/2024 (MT Newswires) -- TE Connectivity ( TEL ) reported fiscal Q3 adjusted earnings Wednesday of $1.91 per diluted share, up from $1.77 a year earlier. Net sales for the quarter ended June 28 were $3.98 billion, down from $4 billion a year earlier. For fiscal Q4, the company said it expects adjusted EPS of approximately $1.94...
Delta flight cancellations on Wednesday fall sharply
Delta flight cancellations on Wednesday fall sharply
Jul 24, 2024
July 24 (Reuters) - Delta Air Lines ( DAL ) reported sharply fewer cancellations Wednesday as the U.S. airline looks to return to normal after cancelling more than 6,000 flights since Friday. The Atlanta-based carrier said as of 6:30 a.m. ET (1030 GMT) it had canceled just 47 flights - only 1% of its flights - compared with 511 on...
Alphabet falls as expenses overshadow quarterly results beat
Alphabet falls as expenses overshadow quarterly results beat
Jul 24, 2024
(Reuters) - Alphabet's shares fell more than 3% in premarket trading on Wednesday after the Google-parent flagged higher expenses due to competition heating up in search and cloud computing. The company reported capital expenditures of $13 billion in the second quarter ending June. Ruth Porat, in her last conference call as Alphabet's chief financial officer, told investors that quarterly capital...
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On
Jul 24, 2024
In Wednesday’s pre-market trading, shares of Novo Nordisk A/S ( NVO ) are witnessing a fall after the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) approved a new indication for Novo Nordisk’s semaglutide, Wegovy, to reduce the risk of heart complications or strokes in overweight and obese adults, What Happened: At the time of writing, Novo Nordisk ( NVO...
Copyright 2023-2026 - www.financetom.com All Rights Reserved